Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Article

  • Targeted Therapy against Human Lung Cancer in Nude Mice by High-Affinity Recombinant Antimesothelin Single-Chain Fv Immunotoxin 1 Supported in part by Cancer Center Support Core Grant CA16672 and Grant R35-CA42107 from the National Cancer Institute, NIH.1
    Dominic Fan, Seiji Yano, Hisashi Shinohara, Carmen Solorzano, Melissa Van Arsdall, Corazon D. Bucana, Sen Pathak, Ewa Kruzel, Roy S. Herbst, Amir Onn, Jennifer S. Roach, Masanori Onda, Qing-cheng Wang, Ira Pastan, Isaiah J. Fidler
    Molecular Cancer Therapeutics Jun 2002, 1 (8) 595-600;
  • Oncostatin M Induces Growth Arrest of Mammary Epithelium via a CCAAT/enhancer-binding Protein δ-dependent Pathway 1 Supported in part by NIH Grant RR00136CA (to J. A. H.) and NIH Grants CA 57607 and P30CA16058 from the National Cancer Institute (to J. W. D.).1
    Julie A. Hutt, James W. DeWille
    Molecular Cancer Therapeutics Jun 2002, 1 (8) 601-610;
  • Characterization of Overlapping XAGE-1 Transcripts Encoding a Cancer Testis Antigen Expressed in Lung, Breast, and Other Types of Cancers
    Kristi A. Egland, Vasantha Kumar, Paul Duray, Ira Pastan
    Molecular Cancer Therapeutics May 2002, 1 (7) 441-450;
  • Molecular Inhibition of Angiogenesis and Metastatic Potential in Human Squamous Cell Carcinomas after Epidermal Growth Factor Receptor Blockade 1 Supported in part by a research award from ImClone Systems Inc.1
    Shyh-Min Huang, Jing Li, Paul M. Harari
    Molecular Cancer Therapeutics May 2002, 1 (7) 507-514;
  • A Prostate-specific Antigen (PSA)-activated Vinblastine Prodrug Selectively Kills PSA-secreting Cells in Vivo
    Deborah DeFeo-Jones, Stephen F. Brady, Dong-Mei Feng, Bradly K. Wong, Trina Bolyar, Kathleen Haskell, David M. Kiefer, Karen Leander, Elizabeth McAvoy, Patricia Lumma, Joseph M. Pawluczyk, Jenny Wai, Sherri L. Motzel, Kevin Keenan, Matthew Van Zwieten, Jiunn H. Lin, Victor M. Garsky, Roger Freidinger, Allen Oliff, Raymond E. Jones
    Molecular Cancer Therapeutics May 2002, 1 (7) 451-459;
  • The Xenoestrogen Bisphenol A Induces Inappropriate Androgen Receptor Activation and Mitogenesis in Prostatic Adenocarcinoma Cells 1 This work was supported by NIH Training Grant ES07250-13 (to Y. B. W.; Environmental Mutagenesis and Cancer) and NIH Grant R01 CA93404-01 (to K. E. K.).1
    Yelena B. Wetherill, Christin E. Petre, Kelly R. Monk, Alvaro Puga, Karen E. Knudsen
    Molecular Cancer Therapeutics May 2002, 1 (7) 515-524;
  • Prolonged Stability and Sustained Prodrug Cell Killing Activity Using Receptor-mediated Delivery of Malarial Circumsporozoite-Cytosine Deaminase Fusion Protein into Liver Cancer Cells 1 Supported by National Cancer Institute Grants CA72404, CA79085 (to M. T. K.) and CA16672 (to M. D. Anderson Cancer Center Core Facility).1
    Yen-Chiu Lin-Lee, Seiichi Nakamura, Varsha Gandhi, Steven A. Curley, Dietrich Stüber, Thomas R. Burkot, M. Tien Kuo
    Molecular Cancer Therapeutics May 2002, 1 (7) 461-467;
  • Inhibition of Retinoblastoma Protein (Rb) Phosphorylation at Serine Sites and an Increase in Rb-E2F Complex Formation by Silibinin in Androgen-dependent Human Prostate Carcinoma LNCaP Cells: Role in Prostate Cancer Prevention 1 This work was supported in part by United States Army Medical Research and Materiel Command Prostate Cancer Program DAMD17-98-1-8588. In part, this work was done during the tenure of the authors at AMC Cancer Research Center, Denver, CO 80262.1
    Alpana Tyagi, Chapla Agarwal, Rajesh Agarwal
    Molecular Cancer Therapeutics May 2002, 1 (7) 525-532;
  • Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis 1 Supported in part by grants from The Susan G. Komen Breast Cancer Foundation (to L. L.) and NIH (to J. L. C.), and by the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children’s Research Hospital.1
    Christina M. Barrett, Felicia L. Lewis, J. Brent Roaten, Trevor W. Sweatman, Mervyn Israel, John L. Cleveland, Leonard Lothstein
    Molecular Cancer Therapeutics May 2002, 1 (7) 469-481;
  • Identification of Differentially Expressed Genes in Human Salivary Gland Tumors by DNA Microarrays 1 Supported by Università di Ferrara, Murst Prin, Carisbo, Carife Grants.1
    Francesca Francioso, Francesco Carinci, Lara Tosi, Luca Scapoli, Furio Pezzetti, Emanuele Passerella, Rita Evangelisti, Antonio Pastore, Stefano Pelucchi, Adriano Piattelli, Corrado Rubini, Massimiliano Fioroni, Paolo Carinci, Stefano Volinia
    Molecular Cancer Therapeutics May 2002, 1 (7) 533-538;

Pages

  • Previous
  • Next
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement